Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report

Medicine (United States)

Volumn 95, Issue 7, 2016, Pages e2243-

  Oliva, Alessandra ^a   Cipolla, Alessia ^a   Gizzi, Francesca ^a   D'Abramo, Alessandra ^a   Favaro, Marco ^b   De Angelis, Massimiliano ^a   Ferretti, Giancarlo ^a   Russo, Gianluca ^a   Iannetta, Marco ^a   Mastroianni, Claudio M ^a   Mascellino, Maria T ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; C REACTIVE PROTEIN; CARBAPENEMASE; COLISTIN; COTRIMOXAZOLE; CREATININE; DEOXYRIBONUCLEOTIDE; ERTAPENEM; GANCICLOVIR; HEMOGLOBIN; HYPERTENSIVE FACTOR; LEVOFLOXACIN; MEROPENEM; TACROLIMUS; TAQ POLYMERASE; UREA; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; THIENAMYCIN DERIVATIVE;

ABDOMINAL DRAINAGE; ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; ANASTOMOSIS; ANTIMICROBIAL THERAPY; ARTERY SURGERY; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BLEEDING TENDENCY; BLOOD ANALYSIS; BLOOD CULTURE; BLOODSTREAM INFECTION; BREATHING RATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE REPORT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; CYTOMEGALOVIRUS; DIASTOLIC BLOOD PRESSURE; DRUG MEGADOSE; DYSPNEA; END STAGE RENAL DISEASE; ENDOARTERECTOMY; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEMALE; FEVER; GRAFT RECIPIENT; HEART RATE; HEMODIALYSIS; HEMORRHAGIC SHOCK; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; ILIAC ARTERY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INOTROPISM; KIDNEY ARTERY STENOSIS; KIDNEY GRAFT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE; LEUKOCYTE COUNT; LUNG LAVAGE; LUNG LOBE; LYMPHOCELE; MEDICAL HISTORY; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PALPATION; PERCUTANEOUS NEPHROSTOMY; PHYSICAL EXAMINATION; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; RISK FACTOR; SOLITARY KIDNEY; STENOTROPHOMONAS MALTOPHILIA; SURGICAL INFECTION; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; URINE CULTURE; UROLOGIC STENT; VIREMIA; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG POTENTIATION; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; KIDNEY TRANSPLANTATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SURGICAL WOUND INFECTION; THIENAMYCINS;

EID: 84959078758     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002243     Document Type: Article

References (21)

1. Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist. 2012;5:133-141.
2. Delgado-Valverde M, Sojo-Dorado J, Pascual A, et al. Clinical management of infections caused by multidrug-resistant Enterobac-teriaceae. Ther Adv Infect Dis. 2013;1:49-69.
3. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440-458.
4. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapene-mase-producing K. pneumoniae: importance of combination therapy. Clin Infec Dis. 2012;55:943-950.
5. Capone A, Giannella M, Fortini D, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19:E23-E30.
6. Oliva A, Gizzi F, Mascellino MT, et al. Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae. Clin Microbiol Infect. 2015 pii: S1198-743X(15)00869-1. doi: 10.1016/j.cmi.2015.09.014.
7. Oliva A, D'Abramo A, D'Agostino C, et al. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Che-mother. 2014;69:1718-1720.
8. Giamarellou H, Galani L, Baziaka F, et al. Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57:2388-2390.
9. Ceccarelli G, Falcone M, Giordano A, et al. Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneu-moniae. Antimicrob Agents Chemother. 2013;57:2900-2901.
10. Kovacs CS Jr, Koval CE, van Duin D, et al. Selecting suitable solid organ transplant donors: reducing the risk of donor-transmitted infections. World J Transplant. 2014;4:43-56.
11. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601-2614.
12. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 7th ed. Wayne, PA: CLSI; 2006. Document M7-A7.
13. Giske CG, Gezelius L, Samuelsen Ø, et al. A sensitive and specific phenotypic assay for detection of metallo-b-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect. 2011;17:552-556.
14. Favaro M, Sarti M, Fontana C. Multiplex real-time PCR probe-based for identification of strains producing: OXA48, VIM, KPC and NDM. World J Microbiol Biotechnol. 2014;30:2995-3001.
15. Nordmann P, Poirel L. The difficult-to-control spread of carbapene-mase producers among Enterobacteriaceae worldwide. Clin Micro-biol Infect. 2014;20:821-830.
16. Epstein L, Hunter JC, Arwady MA, et al. New Delhi metallo-b-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312:1447-1455.
17. Giacobbe DR, Del Bono V, Coppo E, et al. Emergence of a KPC-3-producing Escherichia coli ST69 as a cause of bloodstream infections in Italy. Microbial Drug Resistance. 2015;21:342-344.
18. Lanini S, Nanni Costa A, Puro V. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study. PLoS ONE. 2015;10:e0123706.
19. Giannella M, Bartoletti M, Morelli MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre-and posttransplant colonization. Am J Transplant. 2015;15:1708-1715.
20. Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapene-mase-producing Klebsiella pneumoniae. Antimicrob Agents Che-mother. 2011;55:3002-3004.
21. Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbape-nems? Clin Microbiol Infect. 2011;17:1135-1141.